ReP USP - Resultado da busca

Filtros : "Recchimuzzi, Debora Zachello" Removido: "Mazo, Paulo Eduardo" Limpar

Filtros

Artigo de periodico
METNET: a phase II trial of metformin in patients with well-differentiated neuroendocrine tumours (2022)
Glasberg, Joao; Talans, Aley; Giollo, Thomas Rivelli; Recchimuzzi, Debora Zachello; Bezerra Neto, Joao Evangelista; Lopez, Rossana Veronica Mendonza; Hoff, Paulo Marcelo Gehm ; Riechelmann, Rachel P
Source: Ecancermedicalscience. Unidade: FM
Subjects: NEUROENDOCRINOLOGIA, CARCINOMA NEUROENDÓCRINO, NEOPLASIAS, METFORMINA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GLASBERG, Joao et al. METNET: a phase II trial of metformin in patients with well-differentiated neuroendocrine tumours. Ecancermedicalscience, v. 16, 2022Tradução . . Disponível em: https://doi.org/10.3332/ecancer.2022.1369. Acesso em: 03 nov. 2025.
APA
Glasberg, J., Talans, A., Giollo, T. R., Recchimuzzi, D. Z., Bezerra Neto, J. E., Lopez, R. V. M., et al. (2022). METNET: a phase II trial of metformin in patients with well-differentiated neuroendocrine tumours. Ecancermedicalscience, 16. doi:10.3332/ecancer.2022.1369
NLM
Glasberg J, Talans A, Giollo TR, Recchimuzzi DZ, Bezerra Neto JE, Lopez RVM, Hoff PMG, Riechelmann RP. METNET: a phase II trial of metformin in patients with well-differentiated neuroendocrine tumours [Internet]. Ecancermedicalscience. 2022 ; 16[citado 2025 nov. 03 ] Available from: https://doi.org/10.3332/ecancer.2022.1369
Vancouver
Glasberg J, Talans A, Giollo TR, Recchimuzzi DZ, Bezerra Neto JE, Lopez RVM, Hoff PMG, Riechelmann RP. METNET: a phase II trial of metformin in patients with well-differentiated neuroendocrine tumours [Internet]. Ecancermedicalscience. 2022 ; 16[citado 2025 nov. 03 ] Available from: https://doi.org/10.3332/ecancer.2022.1369
Artigo de periodico
Conversion chemotherapy with a modified FLOX regimen for Borderline or unresectable liver metastases from colorectal cancer: an alternative for limited-resources settings (2019)
Bonadio, Renata Colombo; Divino, Paulo Henrique Amor; Obando, Jorge Santiago Madero; Lima, Karolina Cayres Alvino; Recchimuzzi, Debora Zachello; Kruger, Jaime Arthur Pirola; Saragiotto, Daniel Fernandes; Capareli, Fernanda C.; Hoff, Paulo Marcelo Gehm
Source: Journal of global oncology. Unidade: FM
Subjects: ENVELHECIMENTO, NEOPLASIAS COLORRETAIS, NEOPLASIAS HEPÁTICAS, MEIA IDADE, METÁSTASE NEOPLÁSICA, ESTUDOS RETROSPECTIVOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BONADIO, Renata Colombo et al. Conversion chemotherapy with a modified FLOX regimen for Borderline or unresectable liver metastases from colorectal cancer: an alternative for limited-resources settings. Journal of global oncology, v. 5, 2019Tradução . . Disponível em: https://doi.org/10.1200/JGO.19.00180. Acesso em: 03 nov. 2025.
APA
Bonadio, R. C., Divino, P. H. A., Obando, J. S. M., Lima, K. C. A., Recchimuzzi, D. Z., Kruger, J. A. P., et al. (2019). Conversion chemotherapy with a modified FLOX regimen for Borderline or unresectable liver metastases from colorectal cancer: an alternative for limited-resources settings. Journal of global oncology, 5. doi:10.1200/JGO.19.00180
NLM
Bonadio RC, Divino PHA, Obando JSM, Lima KCA, Recchimuzzi DZ, Kruger JAP, Saragiotto DF, Capareli FC, Hoff PMG. Conversion chemotherapy with a modified FLOX regimen for Borderline or unresectable liver metastases from colorectal cancer: an alternative for limited-resources settings [Internet]. Journal of global oncology. 2019 ; 5[citado 2025 nov. 03 ] Available from: https://doi.org/10.1200/JGO.19.00180
Vancouver
Bonadio RC, Divino PHA, Obando JSM, Lima KCA, Recchimuzzi DZ, Kruger JAP, Saragiotto DF, Capareli FC, Hoff PMG. Conversion chemotherapy with a modified FLOX regimen for Borderline or unresectable liver metastases from colorectal cancer: an alternative for limited-resources settings [Internet]. Journal of global oncology. 2019 ; 5[citado 2025 nov. 03 ] Available from: https://doi.org/10.1200/JGO.19.00180

Digital Library of Intellectual Production of Universidade de São Paulo 2012 - 2025